Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common shares (LCTX)
CUSIP: 53566P109
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common shares
- Total 13F shares
- 75,504,077
- Total 13F value
- $89,104,877
- Share change
- -133,788
- Put/Call ratio
- 0%
- SEC-reported price per share
- $1.18
- Number of holders
- 102
- Value change
- -$402,119
- Number of buys
- 32
- Number of sells
- 32
- Shares outstanding
- 250,425,788
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q3 2023
Institutions
102
Top holders
10
LCTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53566P109
Recent filing periods:
Ownership snapshot
Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BROADWOOD CAPITAL INC
14%
BlackRock Finance, Inc.
3.6%
VANGUARD GROUP INC
2.9%
Defender Capital, LLC.
2%
GEODE CAPITAL MANAGEMENT, LLC
0.97%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
14%
|
$49,259,034
34,935,485 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3.6%
|
$12,707,010
9,012,064 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
2.9%
|
$10,097,995
7,161,699 shares
|
— | 30 Jun 2023 |
| Defender Capital, LLC. |
13F
Company
|
2%
|
$7,204,214
5,109,710 shares
|
— | 30 Jun 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.97%
|
$3,413,339
2,420,808 shares
|
— | 30 Jun 2023 |
| Laurion Capital Management LP |
13F
Company
|
0.79%
|
$2,772,408
1,966,247 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
102
Shares
75,504,077
Rows available
102
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
105
Q3 2023 holders
102
Holder diff
-3
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend